<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1902244942
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2018
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        AQUAFLAM 50 MG SACHET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DICLOFENAC POTASSIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Powder for oral solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        12
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Sachet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="RIYADH PHARMA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 407]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AB05 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Aquaflam belongs to a group of medicines called &ldquo;nonsteroidal anti-inflammatory drugs&rdquo; (NSAIDs), which are used to treat pain and inflammation</p><p>Aquaflam relieves the symptoms of inflammation, such as pain and swelling, and also reduces fever. It has no effect on the causes of inflammation or fever. In migraine attacks, Aquaflam is effective in relieving the headache as well as in improving the accompanying symptoms such as nausea and vomiting</p><p>Aquaflam can be used for short-term treatment of the following conditions</p><ul><li>Sprains, strains, or other injuries</li><li>Pain and swelling after surgery</li><li>Painful menstrual periods</li><li>Migraine attacks</li><li>Back pain, frozen shoulder, tennis elbow, and other forms of soft-tissue rheumatism</li><li>Infections of the ear, nose or throat</li></ul><p>If you have any questions about how Aquaflam works or why this medicine has been prescribed to you, ask your doctor</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Follow all instructions given to you by your doctor or pharmacist carefully, even if they differ from the general information contained in this leaflet</p><p><strong>Do not take Aquaflam</strong></p><ul><li><strong>If you are </strong>allergic to diclofenac potassium or to any of the other ingredients of Aquaflam listed in Section 6 of this leaflet</li><li><strong>If you have </strong>ever had an allergic reaction after taking medicines to treat inflammation or pain (e.g. acetylsalicylic acid, diclofenac or ibuprofen). Reactions may include asthma, runny nose, skin rash, face swelling. If you think you may be allergic, ask your doctor for advice</li><li><strong>If you have </strong>stomach or intestinal ulcer</li><li><strong>If you have or previously </strong>had gastrointestinal bleeding, symptoms of which may include blood in your stools or black stools</li><li><strong>If you suffer </strong>from severe kidney or liver disease</li><li><strong>If you are </strong>in the last three months of pregnancy</li><li><strong>If you have </strong>heart disease (e.g. if you have had a heart attack, have angina or blockages in the arteries of your heart)</li><li><strong>If you have </strong>cerebrovascular disease (e.g. if you have had a stroke, mini-stroke or have blockages of the arteries to the brain).</li><li><strong>If you have </strong>peripheral arterial disease (e.g. poor circulation or blockages of the arteries to the legs and feet)</li><li><strong>If you have </strong>severe heart failure</li></ul><p><strong>If any of these apply to you, tell your doctor and do not take Aquaflam. Your doctor will decide whether this medicine is suitable for you</strong></p><p><strong>Take special care with Aquaflam</strong></p><p>Talk to your doctor or pharmacist before taking your medicine</p><ul><li><strong>if you have </strong>diabetes</li><li><strong>if you </strong>smoke</li><li><strong>If you have </strong>angina, blood clots, high blood pressure, raised cholesterol or raised triglycerides</li><li><strong>If you are taking </strong>Aquaflam simultaneously with other anti-inflammatory medicines including acetylsalicylic acid/aspirin, corticosteroids, &ldquo;blood thinners&rdquo; or SSRIs (see &ldquo;Other medicines and Aquaflam)</li><li><strong>If you have </strong>ever had asthma, other breathing problems (such as COPD) or often get chest infections</li><li><strong>If you have </strong>ever had hay fever or nasal polyps</li><li><strong>If you have </strong>any allergies</li><li><strong>If you have </strong>ever had any gastrointestinal problems such as stomach ulcer, bleeding or black stools, or have experienced stomach discomfort or heartburn after taking anti-inflammatory medicines in the past</li><li><strong>If you have </strong>an inflammation of the colon (ulcerative colitis) or intestinal tract (Crohn&rsquo;s disease)</li><li><strong>If you have or have had </strong>heart problems or high blood pressure</li><li><strong>If you have </strong>liver or kidney problems</li><li><strong>If you could </strong>be dehydrated (e.g. by sickness, diarrhoea, before or after major surgery</li><li><strong>If you have </strong>swollen feet</li><li><strong>If you have </strong>a bleeding disorder or other blood disorders</li><li><strong>If you have </strong>a condition called porphyria</li></ul><p>If you have significant risk factors for cardiovascular disease such as high blood pressure, abnormally high levels of fat (cholesterol, triglycerides) in your blood, diabetes, or if you smoke, and your doctor decides to prescribe Aquaflam, you must use the lowest effective dosage for the shortest duration necessary</p><p><strong>Look out for serious side effects</strong></p><p>Aquaflam can cause some serious side effects. These are listed at the beginning of Section 4. You will need to look out for these while you are taking Aquaflam. If you get a serious side effect you need to stop taking Aquaflam and talk to your doctor straight away. Side effects may be minimized by using the lowest effective dose for the shortest duration necessary</p><p><strong>Risk of heart attack or stroke with Aquaflam</strong></p><p>Medicines such as Aquaflam may be associated with a small increased risk of heart attack (&quot;myocardial infarction&quot;) or stroke. Any risk is more likely with high doses and prolonged treatment. Do not exceed the recommended dose or duration of treatment. If, at any time while taking Aquaflam you experience any signs or symptoms of problems with your heart or blood vessels such as chest pain, shortness of breath, weakness, or slurring of speech, contact your doctor immediately. If you have heart problems, previous stroke or think that you might be at risk of these conditions (for example if you have high blood pressure, diabetes or high cholesterol or are a smoker) you should discuss your treatment with your doctor or pharmacist. Aquaflam may reduce the symptoms of an infection (e.g. headache, high temperature) and may therefore make the infection more difficult to detect and to treat adequately. If you feel unwell and need to see a doctor, remember to mention that you are taking Aquaflam. In very rare cases, Aquaflam, like other anti-inflammatory medicines, may cause severe allergic skin reactions (e.g. rash). Therefore, inform your doctor immediately if you experience such reactions</p><p><strong>Monitoring during your treatment with Aquaflam</strong></p><p>If you have significant risks for heart disease, your doctor will periodically re evaluate whether you should continue treatment with Aquaflam</p><p>If you have any liver impairment, kidney impairment or blood impairment, you will have blood tests during treatment. These will monitor either your liver function (level of transaminases) or your kidney function (level of creatinine) or your blood count (level of white and red blood cells and platelets). Your doctor will take these blood tests into consideration to decide if Aquaflam needs to be discontinued or if the dose needs to be changed</p><p><strong>Children/adolescents</strong></p><p>Aquaflam must not be given to children and adolescents below 14 years of age. For paediatric use, other forms of diclofenac can be used</p><p><strong>Older people</strong></p><p>Elderly patients may be more sensitive to the effects of Aquaflam than other adults. Therefore, they should follow the doctor&rsquo;s instructions particularly carefully and take the minimum number of sachets that provides relief of symptoms. It is especially important for elderly patients to report undesirable effects promptly to their doctor</p><p><strong>Other medicines and Aquaflam</strong></p><p>Please inform your doctor or pharmacist if you are taking or have recently taken any other medicines, even those not prescribed. It is particularly important to tell your doctor if you are taking any of the following medicines</p><ul><li>Lithium or selective serotonin-reuptake inhibitors (SSRIs); (medicines used to treat some type of depression)</li><li>Digoxin (a medicine used for heart problems)</li><li>Diuretics (medicines used to increase the amount of urine)</li><li>ACE inhibitors or beta-blockers (classes of medicines used to treat high blood pressure and heart failure)</li><li>Other anti-inflammatory medicines such as acetylsalicylic acid/aspirin or ibuprofen</li><li>Corticosteroids (medicines used to provide relief for inflamed areas of the body)</li><li>Anticoagulants (blood thinning tablets like warfarin)</li><li>Medicines used to treat diabetes, except insulin</li><li>Methotrexate (a medicine used to treat some kinds of cancer or arthritis)</li><li>Ciclosporin, Tacrolimus ( medicines primarily used in patients who have received organ transplants)</li><li>Trimethoprim (a medicine used to prevent or treat urinary tract infections)</li><li>Quinolone antibacterials (medicines used to treat infection)</li><li>Voriconazole (a medicine used to treat fungal infections)</li><li>Phenytoin (a medicine used to treat seizures)</li></ul><p><strong>Pregnancy and breastfeeding </strong></p><p>If you are pregnant or think that you may be<strong> </strong>pregnant, <strong>tell your doctor</strong>.<strong> </strong>You should not take Aquaflam during the first six<strong> </strong>months of pregnancy unless absolutely necessary.<strong> </strong>As with other anti-inflammatory medicines, you<strong> </strong>must not take Aquaflam during the last 3 months<strong> </strong>of pregnancy, as it could harm your unborn child or<strong> </strong>cause problems at delivery</p><p><strong>Aquaflam </strong>may make it more difficult to become pregnant. You should not take Aquaflam unless necessary if you are planning to become pregnant or if you have problems to become pregnant. You should tell your doctor if you are breast feeding. You should not breast-feed if you are taking Aquaflam, as it might be harmful for your infant</p><p><strong>Driving and using machines</strong></p><p>In rare cases, patients using Aquaflam may experience side effects such as vision disorders, dizziness or drowsiness. If you notice such effects, you should not drive, use machines, or carry out other activities that need careful attention. Tell your doctor as soon as possible if you experience such effects</p><p><strong>Important Information</strong></p><p>Aquaflam contains aspartame, a source of phenylalanine which may be harmful for patients with phenylketonuria</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure</p><p>Do not exceed the recommended dose. It is important that you use the lowest dose that controls your pain and that you do not take Aquaflam for longer than necessary. Your doctor will tell you exactly how many sachets of Aquaflam to take. Depending on how you respond to the treatment, your doctor may suggest a higher or lower dose</p><p><strong>Adults</strong></p><ul><li>For adults, the recommended dose to start the treatment is generally 100 to 150 mg daily (to be taken in 2 to 3 doses). In milder cases, 50 to 100 mg daily are usually sufficient (to be taken in 1 to 2 doses). Do not exceed 150 mg per day</li><li>In painful menstrual periods, start treatment with a single dose of 50 to 100 mg as soon as you feel the first symptoms. Continue with 50 mg up to three times a day for a few days, as needed. If 150 mg a day does not provide sufficient pain relief over 2 to 3 menstrual periods, your doctor may recommend you to take up to 200 mg a day during your next menstrual periods. Do not exceed 200 mg per day</li><li>In migraine, take Aquaflam at the first symptoms of a migraine attack. The initial dose is 50mg.If relief is not obtained within 2 hours, take a further dose of 50 mg. This may be repeated at intervals of 4 to 6 hours, but you should not take more than 200 mg per day</li></ul><p><strong>Children and adolescents</strong></p><p>Aquaflam is not recommended for use in children and adolescents below 14 years of age. For adolescents aged 14 years and over, 50 to 100 mg daily are usually sufficient given as 1 to 2 divided doses. Do not exceed 150 mg per day. The use of Aquaflam in migrane attacks has not been established in children and adolescents</p><p><strong>How to take Aquaflam</strong></p><p>The contents of the sachet should be dissolved by stirring in a glass of non-carbonated water. The solution may remain slightly cloudy, but this should not influence the efficacy of the medicine</p><p><strong>When to take Aquaflam</strong></p><p>The solution should be swallowed preferably before a meal</p><p><strong>If you take more Aquaflam than you should</strong></p><p>If you have accidentally taken more Aquaflam than prescribed, tell your doctor or pharmacist <strong>or go to</strong> <strong>the hospital emergency unit at once </strong>.You may require medical attention</p><p><strong>If you forget to take Aquaflam</strong></p><p>If you miss a dose of Aquaflam, take it as soon as you remember. If it is almost time for your next dose, do not take the missed dose. Take the next dose at your regular time. Do not take two doses to make up for a missed dose</p><p>Do not change the prescribed dose by yourself unless your doctor tells you to</p><p><strong>If you have any further questions on the use of this medicine, ask your doctor or pharmacist</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Aquaflam can cause side effects, although not everybody gets them</p><p>The following side effects may happen with this medicine</p><p><strong>Some side effects could be serious. Stop taking Aquaflam and see a doctor straight away if you notice any of the following serious side effects </strong><strong>&ndash;</strong><strong> you may need urgent medical treatment</strong></p><ul><li>Chest pain or tightness with shortness of breath (may affect between 1 and 10 in every 1000 patients)</li><li>Breathlessness, difficulty of breathing when lying down, swelling of the feet or legs (may affect between 1 and 10 in every 1000 patients)</li><li>Vomiting of blood, bleeding from the bowel (may affect from less than 1 to 10 in every 10,000 patients)</li><li>Sudden slurred speech, facial drooping, weakness, disorientation, or speech problems (may affect from less than 1 to 10 in every 10,000 patients)</li><li>allergic reactions which can include skin rash, itching, bruising, painful red areas, peeling or blistering, wheezing or shortness of breath (&ldquo;bronchospasm&rdquo;), swollen face, lips hands or fingers, hypotension (low blood pressure) and fainting (may affect from less than 1 to 10 in every 10,000 patients)</li></ul><p><strong>The following side effects have also been</strong> <strong>reported in patients taking Aquaflam</strong></p><p>These rare or very rare side effects may affect from less than 1 to 10 in every 10,000 patients</p><ul><li>allergic reactions which can include skin rash, itching, bruising, painful red areas, peeling or blistering, wheezing or shortness of breath (&ldquo;bronchospasm&rdquo;), swollen face, lips , hands or fingers, hypotension (low blood pressure) and fainting</li><li>stomach pain, indigestion, heartburn, wind, feeling sick (nausea), or being sick (vomiting)</li><li>any sign of bleeding in your stomach or intestine, for example, when emptying your bowels, blood in vomit, or black tarry faeces</li><li>yellowing of your skin or the whites of your eyes</li><li>pain in your abdomen and lower back, with feeling or being sick or loss of appetite (possible signs of pancreatitis</li><li>persistent sore throat or high temperature</li><li>an unexpected change in the amount of urine produced and/or its appearance</li><li>bruising more easily than usual</li><li>frequent sore throats or infections</li><li>fits, headaches together with a dislike of bright lights, fever and a stiff neck</li><li>headache and dizziness (signs of high blood pressure, hypertension)</li><li>serious skin rashes including Stevens-Johnson syndrome and Lyell&rsquo;s syndrome</li><li>sudden severe headache, nausea, dizziness, numbness, inability or difficulty to speak, paralysis (possible signs of stroke)</li><li>chest pain (possible sign of heart attack)</li></ul><p>Stop taking Aquaflam and see a doctor straight away if you notice any of the side effects above</p><p><strong>Other side effects</strong></p><p><strong>(Common (may affect up to 1 in 10 people</strong></p><ul><li>stomach pain, heartburn, nausea, vomiting, diarrhoea, indigestion, wind, loss of appetite</li><li>headache, dizziness, vertigo</li><li>skin rash or spots</li><li>raised levels of liver enzymes in the blood</li></ul><p><strong>(Rare (may affect up to 1 in 1,000 people</strong></p><ul><li>stomach ulcers or bleeding (there have been very rarely reported cases resulting in death, particularly in the elderly)</li><li>drowsiness, tiredness</li><li>skin rash and itching</li><li>fluid retention, symptoms of which include swollen ankles</li></ul><p><strong>(Very rare (may affect up to 1 in 10,000 people</strong></p><p><u>Effects on the nervous system</u></p><p>Tingling or numbness in the fingers, tremor, blurred or double vision, hearing loss or impairment, tinnitus (ringing in the ears), sleeplessness, nightmares, mood changes, depression, anxiety, mental health disorders, disorientation and loss of memory</p><p><u>Effects on the stomach and digestive system</u></p><p>(Constipation, inflammation of the tongue, taste changes, mouth ulcers, problems with your food pipe, lower gut disorders (including inflammation of the colon</p><p><u>Effects on the heart, chest or blood</u></p><p>(Palpitations (fast or irregular heart beat), inflammation of blood vessels (vasculitis), inflammation of the lung (pneumonitis), congestive heart failure, blood disorders (including anaemia</p><p><u>Effects on the liver or kidneys</u></p><p>Kidney or liver disorders, presence of blood or protein in the urine</p><p><u>Effects on skin or hair</u></p><p>Skin rashes which may be made worse by exposure to sunlight, hair loss</p><p><strong>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, Please tell your doctor or pharmacist</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- Keep out of reach and sight of children</p><p>- Do not store above 30&deg;C</p><p>- Keep in the original pack to protect from light and moisture</p><p>- Do not use Aquaflam after the expiry date which is stated on the carton .The Expiry date refers to the last day of that month</p><p>- Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. These measures will help protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance in Aquaflam is Diclofenac Potassium, Each sachet contains Diclofenac Potassium (Ph Eur) 50 mg</p><p>Excipients : Potassium Hydrogen Carbonate, Mannitol, Aspartame, Saccharin sodium , Glyceryl behenate, Mint flavor and Aniseed flavor</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Aquaflam is white to off white Powder
Pack: Powder are packed in Alu / Polyethylene / Paper sachet as 900 mg of powder per sachet and 12 sachets per carton

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>(Medical and Cosmetic Products Company Ltd. (Riyadh Pharma</p><p>P.O.Box 442, Riyadh 11411</p><p>Fax: +966 11 265 0505</p><p>Email: contact@riyadhpharma.com</p><p><em>For any information about this medicinal product, please contact the local representative of marketing authorisation holder</em></p><p>Saudi Arabia</p><p>Marketing department</p><p>Riyadh</p><p>Tel: +966 11 265 0111</p><p>Email: marketing@riyadhpharma.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                7/2020
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>أكوافلام ينتمي إلى مجموعة من الأدوية تسمى &quot; مضادات الالتهابات غير الستيرويدية &quot; (NSAIDS) &nbsp;والتي تستخدم لعلاج الألم والالتهاب.</p><p>أكوافلام يخفف من أعراض الالتهاب، مثل الألم والتورم، ويقلل أيضا الحمى. وليس له أي تأثير على أسباب الالتهاب أو الحمى.</p><p>في حالات الصداع النصفي، أكوافلام فعال في تخفيف الصداع وكذلك في تحسين الأعراض المصاحبة مثل الغثيان والقيء.</p><p>أكوافلام يمكن استخدامه كعلاج قصير الأمد في الحالات التالية:</p><ul><li>التواءات، تمزق العضلات، أو الإصابات أخرى.</li><li>ألم وتورم بعد الجراحة.</li><li>فترات الحيض المؤلمة.</li><li>نوبات الصداع النصفي.</li><li>آلام الظهر، الكتف المتيبس، مرفق لاعب التنس ، وغيرها من أشكال روماتيزم الأنسجة الرخوة.</li><li>التهابات الأذن والأنف والحنجرة.</li></ul><p>إذا كان لديك أي أسئلة حول كيفية عمل أكوافلام أو لماذا تم وصف هذا الدواء لك، اسأل طبيبك</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>لا</strong><strong> </strong><strong>تتناول</strong><strong> </strong><strong>أكوافلام</strong></p><ul><li><strong>إذا</strong><strong> </strong><strong>كنت</strong><strong> </strong>تعاني حساسية تجاه ديكلوفيناك بوتاسيوم أو أي من المكونات الأخرى في أكوافلام المدرجة في القسم 6 من هذه النشرة.</li><li><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong>لديك في أي وقت مضى رد فعل تحسسي بعد تناول أدوية لعلاج الالتهاب أو الألم (على سبيل المثال حمض أسيتيل الساليسيليك ، ديكلوفيناك أو ايبوبروفين(، ويمكن أن تشمل ردود الفعل الربو، ورشح الأنف، والطفح الجلدي، وتورم الوجه. إذا كنت تعتقد أنك قد تكون مصاب بالحساسية، اسأل الطبيب الخاص بك للحصول على المشورة.</li><li><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong>لديك قرحة في المعدة أو في الأمعاء.</li><li>إ<strong>ذا</strong><strong> </strong><strong>كان</strong><strong> </strong><strong>لديك</strong><strong> </strong><strong>سابقا</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>حاليا</strong><strong> </strong>نزيف في الجهاز الهضمي أعراضه تشمل الدم في البراز أو البراز الأسود.</li><li><strong>إذا</strong><strong> </strong><strong>كنت</strong><strong> </strong>تعاني من مرض شديد بالكلى أو الكبد .</li><li><strong>إذا</strong><strong> </strong><strong>كنتي</strong><strong> </strong>في الأشهر الثلاثة الأخيرة من الحمل.</li><li><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong>لديك مرض في القلب) على سبيل المثال، إذا كنت تعاني من نوبة قلبية، أو إذا كان لديك ذبحة أو انسداد في شرايين القلب)</li><li><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong>لديك مرض دماغي وعائي (على سبيل المثال، إذا كان لديك سكتة دماغية أو سكتة صغيرة أو لديك انسداد في شرايين المخ)</li><li><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong>لديك مرض شرياني طرفي (على سبيل المثال ضعف الدورة الدموية أو انسداد الشرايين الساقين والقدمين)</li><li><strong>إذا</strong><strong> </strong><strong>كنت</strong><strong> </strong>تعاني من قصور حاد في القلب.</li></ul><p><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>من</strong><strong> </strong><strong>هذا</strong><strong> </strong><strong>ينطبق</strong><strong> </strong><strong>عليك،</strong><strong> </strong><strong>أخبر</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>ولا</strong><strong> </strong><strong>تأخذ أكوافلام</strong><strong>. </strong><strong>طبيبك</strong><strong> </strong><strong>سوف</strong><strong> </strong><strong>يقرر</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong><strong>هذا</strong><strong> </strong><strong>الدواء مناسب لك</strong>.</p><p><strong>الاحتياطات</strong><strong> </strong><strong>عند</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>أكوافلام</strong></p><ul><li><strong>تحدث</strong><strong> </strong><strong>الى</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الصيدلي</strong><strong> </strong><strong>قبل</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>الدواء</strong></li><li><strong>إذا</strong><strong> </strong><strong>كنت</strong><strong> </strong>مصابا بمرض السكري .</li><li><strong>إذا</strong><strong> </strong><strong>كنت</strong><strong> </strong>تدخن .</li><li><strong>إذا</strong><strong> </strong><strong>كنت</strong><strong> </strong>تعاني من الذبحة الصدرية أو جلطات الدم أو ارتفاع ضغط الدم أو ارتفاع الكوليسترول أو ارتفاع الدهون الثلاثية.</li><li><strong>إذا</strong><strong> </strong><strong>كنت</strong><strong> </strong>تتناول أكوافلام في وقت واحد مع أدوية أخرى مضادة للالتهابات بما في ذلك حمض أسيتيل الساليسيليك، الكورتيزون، &nbsp;مخففات لزوجة الدم أو (SSRIs)، انظر (الأدوية الأخرى و أكوافلام)</li><li><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong>لديك في أي وقت مضى مرض الربو، مشاكل التنفس الأخرى (مثل مرض الانسداد الرئوي المزمن) وغالبا ما يحدث التهابات في الصدر .</li><li><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong>لديك في أي وقت مضى حمى القش أو الاورام الحميدة الأنفية.</li><li><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong>لديك أي حساسية .</li><li><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong>لديك في أي وقت مضى أي مشاكل في الجهاز الهضمي مثل قرحة المعدة، والنزيف أو براز أسود، أو اضطرابات المعدة أو حرقة بعد تناول الأدوية المضادة للالتهابات في الماضي.</li><li><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong>لديك التهاب في القولون (التهاب القولون التقرحي( أو الجهاز المعوي (مرض كرون)</li><li><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong>لديك أو كنت تعاني من مشاكل في القلب أو ارتفاع ضغط الدم.</li><li><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong>لديك مشاكل في الكبد أو الكلى.</li><li><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong>من الممكن اصابتك بالجفاف &nbsp;)على سبيل المثال عن طريق المرض والإسهال قبل أو بعد جراحة كبيرة.</li><li>إ<strong>ذا</strong><strong> </strong><strong>كان</strong><strong> </strong>لديك قدم متورمة.</li><li><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong><strong>لديك</strong><strong> </strong>نزيف أو اضطرابات دم أخرى .</li><li><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong><strong>لديك</strong><strong> </strong>حالة تسمى البورفيريا.</li></ul><p>إذا كان لديك عوامل خطر كبيرة لأمراض القلب والأوعية الدموية مثل ارتفاع ضغط الدم، و مستويات غير طبيعية مرتفعة من الدهون (الكولسترول والدهون الثلاثية) في الدم أو السكري أو إذا كنت تدخن، ويقرر طبيبك أن يصف أكوافلام، يجب عليك استخدام أقل جرعة فعالة لأقصر مدة ضرورية.</p><p><strong>انتبه</strong><strong> </strong><strong>للآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>الخطيرة</strong></p><p>أكوافلام يمكن أن يسبب بعض الآثار الجانبية الخطيرة. &nbsp;وهي مدرجة في بداية القسم &nbsp;4</p><p>سوف تحتاج إلى الانتباه لهذه الأثار أثناء العلاج بأكوافلام.إذا حدث أثر جانبي خطير فإنك تحتاج إلى التوقف عن تناول أكوافلام والتحدث إلى الطبيب على الفور. ويمكن تقليل الآثار الجانبية باستخدام أقل جرعة فعالة لأقصر مدة ضرورية</p><p><strong>خطر</strong><strong> </strong><strong>الإصابة</strong><strong> </strong><strong>بأزمة</strong><strong> </strong><strong>قلبية</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>سكتة</strong><strong> </strong><strong>دماغية</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>أكوافلام</strong></p><p>قد يترافق استخدام الأدوية مثل أكوافلام مع زيادة خطر الاصابة بأزمة قلبية ( احتشاء عضلة القلب ( أو السكتة الدماغية. أي خطر يزيد احتمال حدوثه مع جرعات عالية وفترة طويلة من العلاج . لا تتجاوز الجرعة الموصى بها أو مدة العلاج. &nbsp;إذا حدث في أي وقت أثناء استخدام أكوافلام أي علامات أو أعراض للمشاكل مع قلبك أو الأوعية الدموية مثل آلام في الصدر، وضيق في التنفس، وضعف، أو تداخل الكلام، اتصل بطبيبك فورا. إذا كان لديك مشاكل في القلب أو سكتة دماغية سابقة أو تعتقد أنك قد تكون في خطر من هذه الحالات المرضية (على سبيل المثال إذا كان لديك ارتفاع ضغط الدم أو السكري أو ارتفاع الكولسترول أو اذا كنت مدخن) يجب عليك مناقشة العلاج الخاص بك مع الطبيب أو الصيدلي.</p><p>أكوافلام قد يقلل من أعراض العدوى (على سبيل المثال الصداع، وارتفاع في درجة الحرارة(، وبالتالي قد يجعل من الصعب الكشف عن العدوى ومعالجتها بشكل كاف. إذا كنت تشعر بالتوعك وتحتاج إلى رؤية الطبيب، تذكر أن تخبر الطبيب أنك تتناول أكوافلام. في حالات نادرة جدا، أكوافلام مثل الأدوية المضادة للالتهابات الأخرى، قد يسبب ردود فعل شديدة الحساسية للجلد (على سبيل المثال الطفح الجلدي) لذلك، أبلغ الطبيب فورا إذا واجهت مثل هذه الأعراض.</p><p><strong>المراقبة</strong><strong> </strong><strong>أثناء</strong><strong> </strong><strong>العلاج</strong><strong> </strong><strong>بأكوافلام</strong></p><p>إذا كان لديك مخاطر كبيرة لحدوث أمراض القلب، فإن طبيبك دوريا سيعيد تقييم ما إذا كان يجب الاستمرار في العلاج مع أكوافلام .إذا كان لديك أي قصور في الكبد، ضعف الكلى أو ضعف الدم، سيتم عمل اختبارات الدم أثناء العلاج. &nbsp;هذه سوف ترصد إما وظيفة الكبد الخاص بك (مستوى ترانس أميناسيس) أو وظائف الكلى &nbsp;مستوى الكرياتينين) أو تعداد الدم (مستوى خلايا الدم البيضاء والحمراء والصفائح الدموية) سیأخذ طبیبك ھذه الفحوص الدمویة بعین الاعتبار لتقرر ما إذا کان یتعین ايقاف أكوافلام أو إذا کانت الجرعة تحتاج إلی &nbsp;تغيير.</p><p><strong>الأطفال</strong><strong> / </strong><strong>المراهقين</strong></p><p>يجب ألا يوصف أكوافلام للأطفال والمراهقين الذين تقل أعمارهم عن 14 سنة.</p><p>لاستخدام الأطفال ، أشكال أخرى من ديكلوفيناك يمكن استخدامها.</p><p><strong>كبار</strong><strong> </strong><strong>السن</strong></p><p>قد يكون المرضى المسنين أكثر حساسية لتأثير أكوافلام من البالغين الآخرين. وبالتالي، يجب عليهم اتباع تعليمات الطبيب بعناية خاصة وتناول الحد الأدنى من عدد الأكياس التي تستطيع تخفيف الأعراض. ومن المهم بصفة خاصة بالنسبة للمرضى المسنين الإبلاغ عن الآثار غير المرغوب فيها على الفور إلى الطبيب.</p><p><strong>الأدوية</strong><strong> </strong><strong>الأخرى</strong><strong> </strong><strong>وأكوافلام</strong></p><p>الرجاء إبلاغ الطبيب أو الصيدلي إذا كنت تتناول أو تناولت مؤخرا أي أدوية أخرى، حتى الأدوية الغير وصفية. هذا أمر مهم لأن استخدام أكثر من دواء في نفس الوقت يمكنه زيادة أو إضعاف آثار الأدوية.</p><p>أخبر طبيبك إذا كنت تتناول:</p><ul><li>الليثيوم أو مثبطات إعادة امتصاص السيروتونين الانتقائية (SSRIs)، (الأدوية المستخدمة لعلاج بعض أنواع الاكتئاب).</li><li>ديجوكسين (دواء يستخدم لمشاكل في القلب)</li><li>مدرات البول (الأدوية المستخدمة لزيادة كمية البول)</li><li>مثبطات إيس أو حاصرات بيتا (فئات من الأدوية المستخدمة لعلاج ارتفاع ضغط الدم وفشل القلب)</li><li>الأدوية المضادة للالتهابات الأخرى مثل حمض أسيتيل الساليسيليك أو الإيبوبروفين.</li><li>الكورتيكوستيرويدات (الأدوية المستخدمة لعلاج المناطق الملتهبة في الجسم)</li><li>مضادات التخثر (أقراص تقليل لزوجة الدم مثل الوارفارين)</li><li>الأدویة المستخدمة لعلاج مرض السکري، باستثناء الأنسولین.</li><li>ميثوتريكسيت &nbsp;(وهو دواء يستخدم لعاج بعض أنواع السرطان أو التهاب المفاصل)</li><li>السيكلوسبورين، تاكروليموس (الأدوية المستخدمة في المقام الأول لمرضى زراعة الأعضاء)</li><li>تريمثوبريم &nbsp;(دواء يستخدم لمنع أو علاج التهابات المسالك البولية)</li><li>مضادات البكتريا الكينولونية (الأدوية المستخدمة لعلاج العدوى)</li><li>فوريكونازول &nbsp;(دواء يستخدم لعلاج الالتهابات الفطرية)</li><li>الفينيتوين &nbsp;(دواء يستخدم لعلاج التشنجات)</li></ul><p><strong>الحمل</strong><strong> </strong><strong>والرضاعة</strong><strong> </strong><strong>الطبيعية</strong><strong> </strong><strong>والخصوبة</strong></p><p>إذا كنتي حاملا أو تعتقدين أنك حامل، أخبري طبيبك.</p><p>يجب ألا تتناولي أكوافام خلال الأشهر الستة الأولى من الحمل ما لم يكن ضروريا .كما هو الحال مع الأدوية المضادة للالتهابات الأخرى، يجب أن لا تتناولي أكوافلام خلال الأشهر الثلاثة الأخيرة من الحمل، لأنها يمكن أن تضر الجنين الذي لم يولد بعد أو يسبب مشاكل عند الولادة.</p><p>أكوافلام قد يجعل من الصعب أن تصبحي حاما. يجب ألا تتناولي أكوافلام إلا إذا كان ضروريا إذا كنتي تخططين أن تصبحي حاما أو إذا كان لديك مشاكل لتصبحي حاملا. يجب عليكي إخبار طبيبك إذا كنتي ترضعين طفلك رضاعة طبيعية. يجب ألا ترضعي طفلك من الثدي إذا كنتي تتناولين أكوافلام، لأنه قد يكون ضار لطفلك.</p><p><strong>تأثير</strong><strong> </strong><strong>أكوافلام</strong><strong> </strong><strong>على</strong><strong> </strong><strong>القيادة</strong><strong> </strong><strong>واستخدام</strong><strong> </strong><strong>الآلات</strong></p><p>في حالات نادرة، المرضى الذين يستخدمون أكوافلام قد يواجهون آثار جانبية مثل اضطرابات الرؤية، والدوخة أو النعاس. إذا لاحظت مثل هذه الآثار، يجب ألا تقود، أو تستخدم الآلات، أو تقوم بأنشطة أخرى تحتاج إلى عناية فائقة. أخبر طبيبك في أقرب وقت ممكن إذا كنت تواجه مثل هذه الآثار.</p><p><strong>معلومات</strong><strong> </strong><strong>هامة</strong></p><p>أكوافلام يحتوي على الأسبارتام، وهو مصدر للفينيل ألانين الذي قد يكون ضار للمرضى المصابين بالفينيل كيتونيوريا .</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>دائما</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>هذا</strong><strong> </strong><strong>الدواء</strong><strong> </strong><strong>تماما</strong><strong> </strong><strong>كما</strong><strong> </strong><strong>قال</strong><strong> </strong><strong>لك</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الصيدلي</strong><strong>.</strong></p><p><strong>استشر</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الصيدلي</strong><strong> </strong><strong>إذا</strong><strong> </strong><strong>لم</strong><strong> </strong><strong>تكن</strong><strong> </strong><strong>متأكدا</strong>.</p><p>لا تتجاوز الجرعة الموصى بها. من المهم أن تستخدم الجرعة الأقل التي تتحكم في الألم وألا تأخذ أكوافلام لفترة أطول من اللازم. طبيبك سوف يخبرك بالضبط كم عدد أكياس أكوافلام يجب أن تتناول. اعتمادا على استجابتك للعلاج، قد يوصي الطبيب بجرعة أعلى أو أقل.</p><p><strong>البالغين</strong></p><ul><li>للبالغين، الجرعة الموصى بها لبدء العلاج عموما 100-150 ملجم يوميا (تؤخذ في 2-3 جرعات). في الحالات البسيطة 50 إلى 100 ملجم يوميا عادة ما تكون كافية &nbsp;(تؤخذ في 1-2 جرعة). لا تتجاوز 150 ملجم يوميا.</li><li>في فترات الحيض المؤلمة، ابدئي العلاج بجرعة واحدة من 50 إلى 100 ملجم في بداية الأعراض. استمري على جرعة 50 ملجم ثلاث مرات في اليوم لبضعة أيام، حسب الحاجة. &nbsp;إذا كان 150 ملجم يوميا لا يوفر تخفيف الألم &nbsp;بصورة كافية على مدى &nbsp;2-3 حيضات ، قد يوصي الطبيب لكي أن تأخذي ما يصل إلى 200 مجم يوميا خلال فترات الحيض التالية. لا تتجاوزي 200 ملجم يوميا.</li><li>في حالات الصداع النصفي ، تناول أكوافلام في أول أعراض نوبات الصداع النصفي. الجرعة الأولية هي 50 ملجم. إذا لم يتم تخفيف الألم في غضون 2 ساعة، تناول جرعة إضافية 50 ملجم. قد يتكرر هذا على فترات من 4 إلى 6 ساعات، ولكن يجب ألا تأخذ أكثر من 200 ملجم يوميا.</li></ul><p><strong>الأطفال</strong><strong> </strong><strong>والمراهقين</strong></p><p>لا ينصح باستخدام أكوافلام للأطفال والمراهقين الذين تقل أعمارهم عن 14 سنة.</p><p>المراهقين الذين أعمارهم 14 سنة فأكثر، 50 إلى 100 ملجم يوميا تكون كافية وتؤخذ مقسمة على 1-2 جرعة. لا تتجاوز150 ملجم يوميا.</p><p>لم يتم اختبار استخدام أكوافلام في نوبات الصداع النصفي في الأطفال والمراهقين.</p><p><strong>كيفية</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>أكوافلام</strong></p><p>يجب ذوبان محتويات الكيس عن طريق التحريك في كوب من المياه غير الغازية .قد يبقى المحلول غائما قليلا، ولكن هذا لا ينبغي أن يؤثر على فعالية الدواء.</p><p><strong>وقت</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>أكوافلام</strong></p><p>يجب ابتلاع المحلول قبل وجبة الطعام.</p><p><strong>إذا</strong><strong> </strong><strong>تناولت</strong><strong> </strong><strong>أكوافلام</strong><strong> </strong><strong>أكثر</strong><strong> </strong><strong>مما</strong><strong> </strong><strong>يجب</strong></p><p>إذا تناولت أكوافلام أكثر مما تم وصفه لك، أو إذا كان شخص آخر تناول الدواء عن طريق الخطأ، اتصل بالطبيب أو الصيدلي أو اذهب لوحدة الطوارئ بالمستشفى لأنك قد تحتاج إلى عناية طبية.</p><p><strong>إذا</strong><strong> </strong><strong>نسيت</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>أكوافلام</strong></p><p>إذا نسيت تناول الدواء في أي وقت، تناول الدواء في أقرب وقت تتذكره ،اذا حان الوقت لتناول الجرعة المعتادة لا تتناول الجرعة المنسية. تناول الجرعة التالية في وقتها ،لا تتناول جرعتين لتعويض الجرعة المنسية .</p><p>لا تغير الجرعة الموصوفة بنفسك ما لم يخبرك طبيبك بذلك.</p><p><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong><strong>لديك</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>أسئلة</strong><strong> </strong><strong>أخرى</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>استخدام</strong><strong> </strong><strong>هذا</strong><strong> </strong><strong>الدواء،</strong><strong> </strong><strong>اسأل طبيبك</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الصيدلي</strong><strong>.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، يمكن أن يسبب أكوافلام آثارا جانبية على الرغم من أن هذه الآثار لا تحدث لكل شخص.</p><p>الآثار الجانبية التالية قد تحدث مع هذا الدواء.</p><p><strong>بعض</strong><strong> </strong><strong>الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>يمكن</strong><strong> </strong><strong>أن</strong><strong> </strong><strong>تكون</strong><strong> </strong><strong>خطيرة</strong><strong>. </strong><strong>&nbsp;توقف</strong><strong> </strong><strong>عن تناول</strong><strong> </strong><strong>أكوافلام</strong><strong> </strong><strong>وراجع</strong><strong> </strong><strong>الطبيب</strong><strong> </strong><strong>على</strong><strong> </strong><strong>الفور</strong><strong> </strong><strong>إذا</strong><strong> </strong><strong>لاحظت</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>من الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>الخطيرة</strong><strong> </strong><strong>التالية</strong><strong> - </strong><strong>قد</strong><strong> </strong><strong>تحتاج</strong><strong> </strong><strong>إلى</strong><strong> </strong><strong>عناية</strong><strong> </strong><strong>طبية عاجلة</strong><strong>:</strong></p><ul><li>ألم في الصدر أو ضيق مع ضيق في التنفس (قد يؤثر في 1 الى 10 من كل 1000 مريض)</li><li>عدم التنفس، وصعوبة في التنفس عند الاستلقاء، وتورم في القدمين أو الساقين &nbsp;(قد يؤثر في 1 الى 10 &nbsp;من كل 1000 مريض)</li><li>قيء دموي، نزيف من الأمعاء (قد يؤثر في أقل من 1 إلى 10 من كل 10.000 مريض)</li><li>كلام متداخل مفاجئ، وتدلى الوجه، والضعف، والارتباك، أو مشاكل الكلام &nbsp;(قد تؤثر في أقل من 1 إلى 10 من كل 10.000 مريض)</li><li>ردود فعل تحسسية يمكن أن تشمل طفح جلدي، حكة، كدمات، مناطق حمراء مؤلمة، تقشير أو تقرح، أو أزيز أو ضيق في التنفس (&quot;تشنج القصبة الهوائية&quot;)، تورم الوجه، والشفاه اليدين أو الأصابع، انخفاض ضغط الدم والإغماء (قد تؤثر في أقل من 1 إلى 10 من كل 10,000 مريض)</li><li>تشنج خفيف، وألم بالبطن، يبدأ بعد وقت قصير من بداية العلاج بأكوافلام وتليها نزيف في المستقيم أو إسهال دموي عادة يبدأ خلال&nbsp;24&nbsp;ساعة من ظهور آلام في البطن. (التكرار غير معروف، لا يمكن تقديرها من البيانات المتاحة).</li><li>حدوث ألم في الصدر وردود فعل تحسسية من قبيل الصدفة (علامات متلازمة كونيس) (التكرار غير معروف، لا يمكن تقديره من البيانات المتاحة)</li></ul><p><strong>تم</strong><strong> </strong><strong>الإبلاغ</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>التالية</strong><strong> </strong><strong>في</strong><strong> </strong><strong>المرضى</strong><strong> </strong><strong>الذين يتناولون</strong><strong> </strong><strong>أكوافلام</strong></p><p>هذه الآثار الجانبية النادرة أو النادرة جدا قد تؤثر في أقل من 1 إلى 10 من كل 10,000 مريض</p><ul><li>ردود فعل تحسسية يمكن أن تشمل طفح جلدي، حكة، كدمات، مناطق حمراء مؤلمة، تقشير أوتقرح، أزيز أو ضيق في التنفس )&quot;تشنج القصبة الهوائية&quot;(، تورم الوجه والشفتين واليدين أو الأصابع، انخفاض ضغط الدم والإغماء .</li><li>آلام في المعدة، وعسر الهضم، وحرقة، وغازات، والشعور بالمرض (الغثيان) , أو المرض( القيء).</li><li>أي علامة على النزف من المعدة أو الأمعاء، على سبيل المثال عند إفراغ الأمعاء ، و قيء دموي، أو براز قطراني أسود .</li><li>اصفرار جلدك أو بياض عينيك .</li><li>ألم في البطن واسفل الظهر، مع الشعور بالمرض أو فقدان الشهية (علامات محتملة لالتهاب البنكرياس)</li><li>التهاب مستديم في الحلق أو ارتفاع في درجة الحرارة .</li><li>تغير غير متوقع في كمية البول و / أو مظهره .</li><li>التعرض للكدمات أكثر سهولة من المعتاد .</li><li>التهابات متكررة للحلق أو عدوي متكررة .</li><li>نوبات، وصداع جنبا إلى جنب مع كراهية الأضواء الساطعة، والحمى وتيبس الرقبة .</li><li>الصداع والدوار (علامات ارتفاع ضغط الدم)</li><li>طفح جلدي خطير بما في ذلك متلازمة ستيفنز جونسون ومتلازمة ليل .</li><li>صداع مفاجئ قوي ، غثيان، دوار، خدر، عجز أو صعوبة في الكلام، الشلل (علامات محتملة من السكتة الدماغية)</li><li>ألم في الصدر (علامة محتملة للنوبة القلبية). توقف عن تناول أكوافلام واستشر الطبيب على الفور إذا لاحظت أي من الآثار الجانبية أعلاه.</li></ul><p><strong>الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>الأخرى</strong></p><p><strong>شائعة</strong><strong> </strong><strong>&nbsp;(قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>يصل</strong><strong> </strong><strong>إلى</strong><strong> 1 </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 10 </strong><strong>أشخاص</strong><strong>)</strong></p><ul><li>آلام في المعدة، حرقة، غثيان، تقيؤ، إسهال، عسر الهضم،<strong> </strong>ريح، فقدان الشهية .</li><li>صداع، دوار.</li><li>طفح جلدي أو بقع .</li><li>ارتفاع مستويات انزيمات الكبد في الدم .</li></ul><p><strong>نادر</strong><strong> (</strong><strong>قد</strong><strong> </strong><strong>يؤثر</strong><strong> </strong><strong>على</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>يصل</strong><strong> </strong><strong>إلى</strong><strong> 1 </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 1000 </strong><strong>شخص</strong><strong>)</strong></p><ul><li>قرحة المعدة أو النزيف &nbsp;)كانت هناك حالات نادرا ما أبلغ<strong> </strong>عنها مما أدى إلى الموت، ولا سيما في كبار السن)</li><li>النعاس، والتعب .</li><li>طفح جلدي وحكة .</li><li>احتباس السوائل، و أعراضه تشمل انتفاخ الكاحلين .</li></ul><p><strong>نادرة</strong><strong> </strong><strong>جدا</strong><strong> (</strong><strong>قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>يصل</strong><strong> </strong><strong>إلى</strong><strong> 1 </strong><strong>من</strong><strong> </strong><strong>كل </strong><strong>&nbsp;10</strong>,<strong>000</strong><strong>شخص</strong><strong>)</strong></p><p><u>آثار</u><u> </u><u>على</u><u> </u><u>الجهاز</u><u> </u><u>العصبي</u><u>:</u></p><p>وخز أو خدر في الأصابع، ورعشة، وعدم وضوح أو ازدواج الرؤية ، وفقدان السمع أو ضعفه ، طنين )رنين في الأذنين(، عدم النوم، الكوابيس، تغيرات المزاج، والاكتئاب، والقلق، واضطرابات الصحة العقلية، والارتباك وفقدان الذاكرة.</p><p><u>آثار</u><u> </u><u>على</u><u> </u><u>المعدة</u><u> </u><u>والجهاز</u><u> </u><u>الهضمي</u><u>:</u></p><p>الإمساك، والتهاب اللسان، وتغيرات الطعم، تقرحات الفم، مشاكل في المريء ، و اضطرابات في الجزء السفلي من الأمعاء (بما في ذلك التهاب القولون)</p><p><u>آثار</u><u> </u><u>على</u><u> </u><u>القلب</u><u> </u><u>والصدر</u><u> </u><u>أو</u><u> </u><u>الدم</u><u>:</u></p><p>الخفقان ) ضربات القلب سريعة أو غير منتظمة(، والتهاب الأوعية الدموية ،التهاب الرئة ، قصور القلب الاحتقاني، واضطرابات الدم (بما في ذلك فقر الدم)</p><p><u>آثار</u><u> </u><u>على</u><u> </u><u>الكبد</u><u> </u><u>أو</u><u> </u><u>الكلى</u><u>:</u></p><p>اضطرابات الكلى أو الكبد، وجود دم أو بروتين في البول.</p><p><u>آثار</u><u> </u><u>على</u><u> </u><u>الجلد</u><u> </u><u>أو</u><u> </u><u>الشعر</u><u>:</u></p><p>الطفح الجلدي الذي قد يزداد سوءا بسبب التعرض لأشعة الشمس، وفقدان الشعر.</p><p><strong>إذا</strong><strong> </strong><strong>أصبحت</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>من</strong><strong> </strong><strong>الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>خطيرة،</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>إذا</strong><strong> </strong><strong>لاحظت</strong><strong> </strong><strong>أي آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>المذكورة</strong><strong> </strong><strong>في</strong><strong> </strong><strong>هذه</strong><strong> </strong><strong>النشرة، يرجى</strong><strong> </strong><strong>إخبار الطبيب</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الصيدلي</strong><strong>.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ بعيدا عن متناول أيدي ونظر الأطفال.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يحفظ في درجة حرارة أعلى من 30 درجة مئوية.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;يحفظ في العبوة الأصلية للحماية من الضوء والرطوبة.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم أكوافلام بعد تاريخ انتهاء الصلاحية المدون على الشريط وعلى الكرتون. تاريخ انتهاء الصلاحية يشير إلى اليوم الأخير من هذا الشهر.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. هذه التدابير تساعد في حماية&nbsp; البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة في أكوافلام هي ديكلوفيناك بوتاسيوم 50 ملجم، كل كيس يحتوي على ديكلوفيناك بوتاسيوم (دستور الأدوية الأوروبي) 50 &nbsp;ملجم.</p><p>سواغ: بوتاسيوم هيدروجين كاربونيت، مانيتول، أسبارتام، سكارين صوديوم، جليسيريل بيهينات ، نكهة النعناع ونكهة اليانسون.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>أكوافلام مسحوق أبيض الى ابيض داكن.</p><p>العبوة : المسحوق معبأ في أكياس من ألومنيوم / بولي ايثيلين/ورق وكل كيس يحتوي 900 ملجم من المسحوق وكل كرتون يحتوي على 12 كيس.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>شركة المنتجات الطبية والتجميلية المحدودة &nbsp;(الرياض فارما)</p><p>ص.ب &nbsp;442 الرياض 11411</p><p>فاكس :966112650505 +</p><p>البريد الإلكتروني:</p><p>contact@riyadhpharma.com</p><p>لأية معلومات عن هذا المنتج الطبي، يرجى الاتصال على صاحب الترخيص والتسويق:</p><p>المملكة العربية السعودية</p><p>قسم التسويق</p><p>الرياض</p><p>تلفون: 966112650111+</p><p>البريد الإلكتروني:</p><p>marketing@riyadhpharma.com</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            7/2020
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AQUAFLAM ® Sachets 50 mg Powder for Oral Solution.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The active ingredient is potassium [o-(2,6-dichlorophenyl)-amino]-phenyl-acetate (diclofenac potassium)
One sachet contains 50mg diclofenac potassium
One sachet also contains 50mg aspartame (E951)
For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powder for oral solution.
White to off white  powder for oral solution.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Short-term treatment of all grades of pain and inflammation in the following acute conditions:</p><ul><li>Post traumatic pain, inflammation and swelling, e.g. due to sprains.</li><li>&nbsp;Acute musculo-skeletal disorders such as periarthritis (for example frozen shoulder).</li><li>Post-operative pain, inflammation and swelling, e.g. following dental or orthopaedic surgery.</li><li>Painful and/or inflammatory conditions in gynaecology, e.g. primary dysmenorrhoea or adnexitis and associated menorrhagia.</li><li>Migraine attacks.</li><li>Painful syndromes of the vertebral column.</li><li>Non-articular rheumatism.</li><li>As an adjuvant in severe painful inflammatory infections of the ear, nose, or throat, e.g. pharyngotonsillitis,&nbsp;otitis. In keeping with general therapeutic principles, the underlying disease should be treated with basic &nbsp;&nbsp;therapy, as appropriate. Fever alone is not an indication.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4).</p><p>The contents of the sachet should be dissolved with stirring in a glass of natural (non-carbonated) water. The solution may remain slightly opalescent, but this should not influence the efficacy of the preparation. The solution should be swallowed preferably before meals.</p><p><strong>Adults</strong></p><p>The recommended initial daily dosage is 100-150mg. In milder cases, 50-100mg daily are usually sufficient. The daily dosage should generally be divided up to 3 doses.</p><p>In primary dysmenorrhoea the daily dosage should be individually adjusted and is generally 50-150mg. Initially a dose of 50-100mg should be given and, if necessary, raised in the course of several menstrual cycles up to a maximum of 200 mg/day. Treatment should be started upon appearance of the first symptoms and, depending on the symptomatology, continued for a few days.</p><p>In migraine an initial dose of 50mg should be taken at the first signs of an impending attack. In cases where pain relief within 2 hours after the first dose is not sufficient, a further dose of 50mg may be taken. If needed, further doses of 50mg may be taken at intervals of 4-6 hours, not exceeding a total dose of 200mg per day.</p><p><strong>Children and adolescents</strong></p><p>AQUAFLAM 50mg powder for oral solution is not recommended for use in children and adolescents below 14 years of age.</p><p>For treatment in children and adolescents below 14 years of age, oral drops and suppositories of diclofenac 12.5mg are available.</p><p>For adolescents aged 14 years and over, 50 to 100mg daily are usually sufficient, given as 1 to 2 divided doses.</p><p>The maximum daily dose of 150mg should not be exceeded.</p><p>The use of AQUAFLAM 50mg powder for oral solution in migraine attacks has not been established in children and</p><p>adolescents.</p><p><strong>Older people (Patients aged 65 or above)</strong></p><p>Although the pharmacokinetics of &nbsp;AQUAFLAM are not impaired to any clinically relevant extent in elderly patients, nonsteroidal anti-inflammatory drugs should be used with particular caution in older patients who generally are more prone to adverse reactions. In particular, it is recommended that the lowest effective dosage be used in frail elderly patients or those with a low body weight (see also precautions).Treatment should be reviewed at regular intervals and discontinued if no benefit is seen or if intolerance occurs.</p><p><strong>Renal impairment</strong></p><p>Diclofenac is contraindicated in patients with severe renal impairment (see section 4.3).</p><p>No specific studies have been carried out in patients with renal impairment, therefore, no specific dose adjustment</p><p>recommendations can be made.</p><p>Caution is advised when administering diclofenac to patients with mild to moderate renal impairment (see section 4.3 and 4.4).</p><p><strong>Hepatic impairment</strong></p><p>Diclofenac is contraindicated in patients with severe hepatic impairment (see section 4.3).</p><p>No specific studies have been carried out in patients with hepatic impairment, therefore, no specific dose adjustment recommendations can be made.</p><p>Caution is advised when administering diclofenac to patients with mild to moderate hepatic impairment (see section 4.3 and 4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                • Known hypersensitivity to the active substance or to any of the excipients listed in Section 6.1
• Active gastric or intestinal ulcer, bleeding or perforation
• History of gastrointestinal bleeding or perforation, related to previous NSAIDs therapy. Active or history of  recurrent peptic ulcer/ haemorrhage (two or more distinct episodes of proven ulceration or bleeding).
• Last trimester of pregnancy (see section 4.6 Pregnancy and lactation)
• Hepatic failure
• Chronic Kidney Disease Grade 5 (GFR <15)
• Established congestive heart failure (NYHA II-IV), ischemic heart disease, peripheral arterial disease and/or cerebrovascular disease.
• Like other non-steroidal anti-inflammatory drugs (NSAIDs), AQUAFLAM is also contraindicated in patients in whom attacks of asthma, urticaria, or acute rhinitis are precipitated by acetylsalicylic acid or other NSAIDs.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>General</strong></p><p>Undesirable effects may be minimised by using the lowest effective dose for the shortest possible duration necessary to control symptoms (see section 4.2 Posology and GI and cardiovascular risks below).</p><p>The concomitant use of AQUAFLAM with systemic NSAIDs including cyclooxygenase-2 selective inhibitors, should be</p><p>avoided due to the absence of any evidence demonstrating synergistic benefits and the potential for additive undesirable effects.</p><p>Caution is indicated in the elderly on basic medical grounds. In particular it is recommended that the lowest effective dose be used in frail elderly patients or those with a low body weight.</p><p>Like other NSAIDs, AQUAFLAM may mask the signs and symptoms of infection due to its pharmacodynamics properties.</p><p>AQUAFLAM contains a source of phenylalanine and may be therefore harmful for patients with phenylketonuria.</p><p>The use of diclofenac potassium may impair female fertility and is not recommended in women attempting to conceive.</p><p>In women who have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of diclofenac potassium should be considered.</p><p><strong>Gastrointestinal effects</strong></p><p>Gastrointestinal bleeding ulceration or perforation, which can be fatal has been reported with all NSAIDs, including</p><p>diclofenac and may occur at any time during treatment with or without warning symptoms or a previous history of</p><p>serious gastrointestinal events. The elderly have an increased frequency of adverse reactions to NSAIDs especially</p><p>gastrointestinal bleeding and perforation which may be fatal (see section 4.2 Posology and method of administration).</p><p>When gastrointestinal bleeding or ulceration occurs in patients receiving AQUAFLAM, the medicinal product should be withdrawn.</p><p>As with all NSAIDs, including diclofenac, close medical surveillance is imperative and particular caution should be</p><p>exercised when prescribing AQUAFLAM in patients with symptoms indicative of gastrointestinal (GI) disorders or with a history suggestive of gastric or intestinal ulceration, bleeding or perforation (see section 4.8 Undesirable effects). The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses, in patients with a history of ulcer,</p><p>particularly if complicated with haemorrhage or perforation (see section 4.3 Contra-indications) The elderly have an increased frequency of adverse reactions to NSAIDs especially gastrointestinal bleeding and perforation which may be fatal (see Section 4.2)</p><p>To reduce the risk of GI toxicity in patients with a history of ulcer, particularly if complicated with haemorrhage or</p><p>perforation, and in the elderly, the treatment should be initiated and maintained at the lowest effective dose.</p><p>Combination therapy with protective agents (e.g. proton pump inhibitors or misoprostol) should be considered for these patients, and also for patients requiring concomitant use of medicinal products containing low-dose acetylsalicylic acid (ASA)/aspirin or other medicinal products likely to increase gastrointestinal risk (see below and section 4.5 Interactions with other medicinal products and other form of interaction).</p><p>Patients with a history of GI toxicity, particularly the elderly, should report any unusual abdominal symptoms</p><p>(especially GI bleeding) particularly in the initial stages of treatment. Caution is recommended in patients receiving</p><p>concomitant medications which could increase the risk of ulceration or bleeding, such as oral corticosteroids,</p><p>anticoagulants such as warfarin, anti-platelet agents such as aspirin or selective serotonin-reuptake inhibitors (see</p><p>section 4.5 Interaction with other medicinal products and other forms of interaction).</p><p>Close medical surveillance and caution should also be exercised in patients with ulcerative colitis or Crohn&rsquo;s disease, as their condition may be exacerbated (see section 4.8 Undesirable effects).</p><p><strong>Hepatic effects</strong></p><p>Close medical surveillance is required when prescribing AQUAFLAM to patients with impaired hepatic function, as their condition may be exacerbated.</p><p>As with other NSAIDs, including diclofenac , values of one or more liver enzymes may increase. During prolonged</p><p>treatment with diclofenac, regular monitoring of hepatic function is indicated as a precautionary measure. If abnormal liver function tests persist or worsen, if clinical signs or symptoms consistent with liver disease develop, or if other manifestations occur (e.g. eosinophilia, rash etc.), AQUAFLAM should be discontinued. Hepatitis may occur with use of diclofenac , without prodromal symptoms.</p><p>Caution is called for when using diclofenac in patients with hepatic porphyria, since it may trigger an attack.</p><p><strong>Renal effects</strong></p><p>As fluid retention and oedema have been reported in association with NSAID therapy, including diclofenac, particular caution is called for in patients with impaired cardiac or renal function ,history of hypertension ,the elderly, patients receiving concomitant treatment with diuretics or medicinal products that can significantly impact renal function, and in those patients with substantial extracellular volume depletion from any cause, e.g. before or after major surgery (see section 4.3 Contraindications) .Monitoring of renal function is recommended as a precautionary measure when using AQUAFLAM in such cases. Discontinuation of therapy is normally followed by a recovery to the pre-treatment state.</p><p><strong>Skin Effects</strong></p><p>Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome and toxic</p><p>epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs, including AQUAFLAM (see</p><p>section 4.8 Undesirable effects). Patients appear to be at highest risk of these reactions early in the course of therapy, the onset of the reaction occurring in the majority of cases within the first month of treatment. AQUAFLAM should be discontinued at the first appearance of skin rash, mucosal lesions or any other sign of hypersensitivity. As with other NSAIDs, allergic reactions, including anaphylactic/anaphylactoid reactions, can also occur in rare cases with diclofenac without earlier exposure to the drug.</p><p><strong>Cardiovascular and cerebrovascular effects</strong></p><p>Appropriate monitoring and advice are required for patients with a history of hypertension and/or congestive heart</p><p>failure (NYHA-1) as fluid retention and oedema have been reported in association with NSAID therapy.</p><p>Clinical trial and epidemiological data suggest that the use of diclofenac, particularly at high doses (150 mg daily) and in long term treatment may be associated with a small increased risk of arterial thrombotic events (for example</p><p>myocardial infarction or stroke).</p><p>Patients with congestive heart failure (NYHA-1), and patients with significant risk factors for cardiovascular events</p><p>(e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking) should only be treated with diclofenac after careful</p><p>consideration. As the cardiovascular risks of diclofenac may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. The patient&#39;s need for symptomatic relief and response to therapy should be re-evaluated periodically.</p><p>Patients should remain alert for the signs and symptoms of serious arteriothrombotic events (e.g. chest pain, shortness of breath, weakness, slurring of speech), which can occur without warnings. Patients should be instructed to see a physician immediately in case of such an event.</p><p><strong>Haematological effects</strong></p><p>Use of AQUAFLAM is recommended only for short-term treatment. If, however, AQUAFLAM is used for a prolonged period,</p><p>monitoring of the blood count is recommended, as with other NSAIDs.</p><p>Like other NSAIDs, AQUAFLAM may temporarily inhibit platelet aggregation .Patients with defects of haemostasis should be carefully monitored.</p><p><strong>Pre-existing asthma</strong></p><p>In patients with asthma, seasonal allergic rhinitis, swelling of the nasal mucosa (i.e. nasal polyps), chronic obstructive pulmonary diseases or chronic infections of the respiratory tract (especially if linked to allergic rhinitis-like symptoms), reactions on NSAIDs like asthma exacerbations (so-called intolerance to analgesics/analgesics-asthma), Quincke&rsquo;s oedema or urticaria are more frequent than in other patients. Therefore, special precaution is recommended in such patients (readiness for emergency). This is applicable as well for patients who are allergic to other substances, e.g. with skin reactions, pruritus or urticaria.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>(Including interactions observed with other dosage forms of diclofenac potassium and diclofenac sodium)</p><p><strong><em>Observed Interactions to be considered:</em></strong></p><p><strong><em>Potent CYP2C9 inhibitors: </em></strong>Caution is recommended when co-prescribing diclofenac with potent CYP2C9 inhibitors (such as voriconazole), which could result in a significant increase in peak plasma concentrations and exposure to diclofenac due to inhibition of diclofenac metabolism.</p><p><em>Lithium: </em>If used concomitantly, diclofenac may increase plasma concentrations of lithium. Monitoring of the serum</p><p>lithium level is recommended.</p><p><em>Digoxin: </em>If used concomitantly, diclofenac may increase plasma concentrations of digoxin. Monitoring of the serum digoxin level is recommended.</p><p><em>Diuretics and antihypertensive drugs: </em>Like other NSAIDs, concomitant use of diclofenac with diuretics or</p><p>antihypertensive drugs (e.g.beta-blockers, angiotensin converting enzyme (ACE) inhibitors may cause a decrease in their antihypertensive effect. Therefore, the combination should be administered with caution and patients, especially the elderly, should be periodically monitored. Patients should be adequately hydrated and consideration should be given to monitoring of renal function after initiation of concomitant therapy and periodically thereafter, particularly for diuretics and ACE inhibitors due to the increased risk of nephrotoxicity. (see section 4.4 Special warnings and precautions for use).</p><p><em>Ciclosporin: </em>Diclofenac, like other NSAIDs, may increase the nephrotoxicity of ciclosporin due to the effect on renal prostaglandins. Therefore, it should be given at doses lower than those that would be used in patients not receiving ciclosporin.</p><p><strong><em>Drugs known to cause hyperkalemia</em></strong>: Concomitant treatment with potassium-sparing diuretics, ciclosporin, tacrolimus or trimethoprim may be associated with increased serum potassium levels, which should therefore be monitored frequently (see section 4.4 Special warnings and precautions for use).</p><p><em>Quinolone antibacterials</em>: There have been isolated reports of convulsions which may have been due to concomitant use of quinolones and NSAIDs</p><p><strong><em>Anticipated Interactions to be considered</em></strong></p><p><em>Other NSAIDs and corticosteroids: </em>Concomitant administration of diclofenac and other systemic NSAIDs or corticosteroids may increase the risk of gastrointestinal bleeding (see Section 4.4 special warnings and precautions for use)<em>.</em></p><p><em>Anticoagulant and anti-platlet agents: </em><strong>Caution is recommended since concomitant administration could increase the risk of bleeding see section 4.4. </strong>Although clinical investigations do not appear to indicate that diclofenac affects<strong> </strong>the action of anticoagulants, there are also isolated reports of an increased risk of haemorrhage in patients receiving<strong> </strong>diclofenac and anticoagulants concomitantly. Close monitoring of such patients is therefore recommended.</p><p><em>Selective serotonin reuptake inhibitors (SSRIs): </em>Concomitant administration of systemic NSAIDs including diclofenac and SSRIs may increase the risk of gastrointestinal bleeding (see section 4.4 Special warnings and precautions for use)</p><p><em>Antidiabetics: </em>Clinical studies have shown that diclofenac can be given together with oral antidiabetic agents without influencing their clinical effect. However, there have been isolated reports of both hypoglycaemic and hyperglycaemic effects necessitating changes in the dosage of the antidiabetic agents during treatment with diclofenac. For this reason, monitoring of the blood glucose level is recommended as a precautionary measure during concomitant therapy.</p><p><em>Methotrexate: </em>Diclofenac can inhibit the tubular renal clearance of methotrexate hereby increasing methotrexate levels.</p><p>Caution is recommended when NSAIDs including diclofenac are administered less than 24 hours before or after treatment with methotrexate, since blood concentrations of methotrexate may rise and the toxicity of this substance be increased.</p><p><strong><em>Phenytoin: </em></strong>When using phenytoin concomitantly with diclofenac, monitoring of phenytoin plasma concentrations is recommended due to an expected increase in exposure to phenytoin</p><p><strong>Colestipol and cholestyramine</strong>: These agents can induce a delay or decrease in absorption of diclofenac. Therefore, it is recommended to administer diclofenac at least one hour before or 4 to 6 hours after administration of colestipol / cholestyramine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong></p><p>Inhibition of prostaglandin synthesis may adversely affect the pregnancy and/or the embryo/foetal development. Data from epidemiological studies suggest an increased risk of miscarriage and of cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk for cardiovascular malformation was increased from less than 1%, up to approximately 1.5 %.</p><p>The risk is believed to increase with dose and duration of therapy. In animals, administration of a prostaglandin synthesis inhibitor has been shown to result in increased pre- and post-implantation loss and embryo-foetal lethality.</p><p>In addition, increased incidences of various malformations, including cardiovascular, have been reported in animals given a prostaglandin synthesis inhibitor during the organogenetic period. During the first and second trimester of pregnancy, diclofenac should not be given unless clearly necessary. If diclofenac is used by a woman attempting to conceive, or during the first and second trimester of pregnancy, the dose should be kept as low and duration of treatment as short as possible.</p><p>During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the foetus to:</p><p>- cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension);</p><p>- renal dysfunction, which may progress to renal failure with oligo-hydroamniosis;</p><p>&nbsp; the mother and the neonate, at the end of pregnancy, to:</p><p>- possible prolongation of bleeding time, an anti-aggregating effect which may occur even at very low doses.</p><p>- inhibition of uterine contractions resulting in delayed or prolonged labour.</p><p>&nbsp; Consequently, diclofenac is contraindicated during the third trimester of pregnancy.</p><p><strong>Lactation</strong></p><p>Like other NSAIDs, diclofenac passes into the breast milk but in small amounts. Therefore, AQUAFLAM should not be administered during breast feeding in order to avoid undesirable effects in the infant.</p><p><strong>Fertility</strong></p><p>As with other NSAIDs, the use of AQUAFLAM may impair female fertility and is not recommended in women attempting to conceive. In women who have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of AQUAFLAM should be considered.</p><p><strong>&nbsp;</strong></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients who experience dizziness, vertigo, somnolence or other central nervous system disturbances while taking</p><p>AQUAFLAM, including visual disturbances, should not drive or operate machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse drug reactions from clinical trials and/or spontaneous or literature cases (Table 1) are listed by MedRA system order class. Within each system organ class, the adverse drug reactions are ranked by frequency, with the most frequent reactions first. Within each frequency grouping, adverse drug reactions are presented in order of decreasing seriousness. In addition, the corresponding frequency category for each adverse drug reaction is based on the following convention: (CIOMS III): very common (&gt;1/10); common (_ 1/100, &lt; 1/10); uncommon (_ 1/1,000, &lt; 1/100); rare (_1/10,000, &lt; 1/1,000); very rare (&lt; 1/10,000).</p><p>The most commonly observed adverse events are gastrointestinal in nature. Peptic ulcers, perforation or GI bleeding, sometimes fatal, particularly in the elderly, may occur (see section 4.4 Special warnings and precautions for use).</p><p>Nausea, vomiting, diarrhoea, flatulence, constipation, dyspepsia, abdominal pain, melaena, haematemesis, ulcerative stomatitis, exacerbation of coilitis and Crohn&rsquo;s disease (see section 4.4 Special warnings and precautions for use) have been reported following administration. Less frequently, gastritis has been observed.</p><p>The following table of undesirable effects include those reported with AQUAFLAM powder for oral solution and/or other pharmaceutical forms of diclofenac, with either short-term or long-term use.</p><p><strong>Table 1</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="2"><p><strong>Blood and lymphatic system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td><p>Thrombocytopenia, leucopenia, anemia (including</p><p>haemolytic anemia and aplastic anemia),</p><p>agranulocytosis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td><p>Hypersensitivity, anaphylactic and anaphylactoid</p><p>reactions (including hypotension and shock).</p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td><p>Angioedema (including face edema).</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Psychiatric disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td><p>Disorientation, depression, insomnia, nightmare,</p><p>irritability, psychotic reactions.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Nervous system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common:</p></td><td><p>Headache, dizziness.</p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td><p>Somnolence.</p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td><p>Paresthesias, memory impairment, convulsions,</p><p>anxiety, tremor, meningitis aseptic, dysgeusia,</p><p>cerebrovascular accident.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Eye disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td><p>Visual impairment(blurred vision, diplopia).</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Ear and labyrinth</strong></p><p><strong>disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common:</p></td><td><p>Vertigo.</p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td><p>Tinnitus, hearing impaired.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Cardiac disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon*:</p></td><td style="vertical-align:top"><p>Uncommon*: Myocardial infarction, cardiac failure, palpitations, chest pain</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Vascular disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td><p>Hypertension, vasculitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Respiratory, thoracic and</strong></p><p><strong>mediastinal disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Asthma/bronchospasm (including dyspnea).</p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Pneumonitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Gastrointestinal</strong></p><p><strong>disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common:</p></td><td style="vertical-align:top"><p>Nausea, vomiting, diarrhea, dyspepsia, abdominal pain, flatulence, decreased appetite.</p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Gastritis, gastrointestinal hemorrhage, hematemesis,</p><p>melena, diarrhea hemorrhagic, gastrointestinal ulcer</p><p>(with or without bleeding or perforation).</p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td><p>Colitis (including haemorrhagic colitis and</p><p>exacerbation of ulcerative colitis or Crohn&#39;s disease),</p><p>constipation, stomatitis (including ulcerative</p><p>stomatitis), glossitis,</p><p>esophageal disorder, diaphragm-like intestinal</p><p>strictures, pancreatitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Hepatobiliary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common:</p></td><td><p>Transaminases increased.</p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td><p>Hepatitis with or without jaundice, liver disorder.</p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td><p>Hepatitis fulminant, hepatic necrosis, hepatic failure.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common:</p></td><td style="vertical-align:top"><p>Rash.</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Urticaria.</p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td><p>Dermatitis bullous , eczema, erythema, erythema</p><p>multiforme, Stevens-Johnson syndrome, toxic</p><p>epidermal necrolysis (Lyell&#39;s syndrome), dermatitis</p><p>exfoliative, alopecia, photosensitivity reaction,</p><p>Henoch-Schonlein purpura, allergic purpura], pruritus.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Renal and urinary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td><p>Renal failure acute, haematuria, proteinuria, nephritic</p><p>syndrome, tubulointerstitial nephritis, renal papillary</p><p>necrosis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>General disorders and administration site conditions</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Edema.</p></td></tr></tbody></table><p><strong>*The frequency reflects data from long-term treatment with a high dose (150 mg/day).</strong></p><p>Clinical trial and epidemiological data consistently point towards an increased risk of arterial thrombotic events (for</p><p>example myocardial infarction or stroke) associated with the use of diclofenac, particularly at high doses (150 mg</p><p>daily) and in long term treatment (see section 4.3 and 4.4 for Contraindications and Special warnings and special</p><p>precautions for use).</p><p>Oedema, hypertension and cardiac failure have been reported in association with NSAID treatment.</p><p><strong><u>Reporting of suspected adverse reactions</u></strong></p><p>The National Pharmacovigilance Center (NPC):</p><p>Fax: +966-11-205-7662</p><p>Call NPC at +966-11-2038222, Ext 2317-2356-2340</p><p>SFDA Call Center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Symptoms</strong></p><p>There is no typical clinical picture resulting from diclofenac overdosage. Overdosage can cause symptoms such as vomiting, gastrointestinal haemorrhage, diarrhoea, dizziness, tinnitus or convulsions. In the event of significant poisoning, acute renal failure and liver damage are possible.</p><p><strong>Therapeutic measures</strong></p><p>Management of acute poisoning with NSAIDs including diclofenac consists essentially of supportive measures and symptomatic treatment. Supportive measures and symptomatic treatment should be given for complications such as hypotension, renal failure, convulsions, gastrointestinal disorder, and respiratory depression.</p><p>Special measures such as forced diuresis, dialysis, or haemoperfusion are probably unlikely to be helpful in accelerating the elimination of NSAIDs including diclofenac because of their high protein binding rate and extensive metabolism.</p><p>Activated charcoal may be considered after ingestion of a potentially toxic overdose, and gastric decontamination (e.g. vomiting, gastric lavage) after ingestion of a potentially life-threatening overdose.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Anti-inflammatory and antirheumatic products, non-steroids, acetic acid derivatives and related substances (ATC code: M01A B05).</p><p><strong>Mechanism of action</strong></p><p>AQUAFLAM contains the potassium salt of diclofenac, a non-steroidal compound with pronounced analgesic, antiinflammatory, and antipyretic properties.</p><p>AQUAFLAM has a rapid onset of action, which makes it particularly suitable for the treatment of acute painful and inflammatory conditions. Inhibition of prostaglandin biosynthesis, which has been demonstrated in experiments, is considered to be fundamental to its mechanism of action. Prostaglandins play a major role in causing inflammation, pain and fever.</p><p>Diclofenac potassium <em>in vitro </em>does not suppress proteoglycan biosynthesis in cartilage at concentrations equivalent to the concentrations reached in humans.</p><p><strong>Pharmacodynamic effects</strong></p><p>AQUAFLAM has been found to exert a pronounced analgesic effect in moderate and severe pain. In the presence of inflammation, e.g. due to trauma or following surgical interventions, it rapidly relieves both spontaneous pain and pain on movement and diminishes inflammatory swelling and wound oedema. Clinical studies have also revealed that in primary dysmenorrhoea the active substance is capable of relieving the pain and reducing the extent of bleeding. In migraine attacks AQUAFLAM has been shown to be effective in relieving the headache and in improving the accompanying symptoms nausea and vomiting.</p><p>There is limited clinical trial experience of the use of diclofenac in Juvenile Rheumatoid Arthritis (JRA)/Juvenile Idiopathic Arthritis (JIA) paediatric patients. In a randomized, double-blind, 2-week, parallel group study in children aged 3-15 years with JRA/JIA, the efficacy and safety of daily 2-3 mg/kg BW diclofenac was compared with acetylsalicylic acid (ASS, 50-100 mg/kg BW/d) and placebo &ndash; 15 patients in each group. In the global evaluation, 11 of 15 diclofenac patients, 6 of 12 aspirin and 4 of 15 placebo patients showed improvement with the difference being statistically significant (p &lt; 0.05). The number of tender joints decreased with diclofenac and ASS but increased with placebo. In a second randomized, double-blind, 6-week, parallel group study in children aged 4-15 years with JRA/JIA, the efficacy of diclofenac (daily dose 2-3 mg/kg BW, n=22) was comparable with that of indomethacin (daily dose 2-3mg/kg BW, n=23).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption</strong></p><p>Diclofenac is rapidly and completely absorbed from diclofenac potassium. Mean peak plasma concentrations of 5.5 micromol/L are attained after 5-20 minutes after ingestion of one sachet of 50mg.</p><p>Ingestion together with food is expected to have no influence on the amount of diclofenac absorbed although onset and rate of absorption may be slightly delayed.The amount absorbed is in linear proportion to the size of the dose.</p><p>Since about half of diclofenac is metabolized during its first passage through the liver (&quot;first pass&quot; effect), the area under the concentration curve (AUC) is about half as large following oral or rectal administration as it is following a parenteral dose of equal size.</p><p>Pharmacokinetic behaviour does not change after repeated administration. No accumulation occurs provided the recommended dosage intervals are observed.</p><p><strong>Distribution</strong></p><p>99.7% of diclofenac binds to serum proteins, mainly to albumin (99.4%). The apparent volume of distribution calculated is 0.12-0.17 L/kg.</p><p>Diclofenac enters the synovial fluid, where maximum concentrations are measured 2-4 hours after peak plasma values have been reached. The apparent half-life for elimination from the synovial fluid is 3-6 hours. Two hours after reaching peak plasma levels, concentrations of the active substance are already higher in the synovial fluid than in the plasma, and they remain higher for up to 12 hours.</p><p>Diclofenac was detected in a low concentration (100 ng/mL) in breast milk in one nursing mother. The estimated amount ingested by an infant consuming breast milk is equivalent to a 0.03 mg/kg/day dose.</p><p><strong>Biotransformation/Metabolism</strong></p><p>Biotransformation of diclofenac takes place partly by glucuronidation of the intact molecule, but mainly by single and multiple hydroxylation and methoxylation, resulting in several phenolic metabolites (3&#39;-hydroxy-, 4&#39;-hydroxy-, 5- hydroxy-, 4&#39;,5-dihydroxy-, and 3&#39;-hydroxy-4&#39;-methoxy-diclofenac), most of which are converted to glucuronide conjugates. Two of these phenolic metabolites are biologically active, but to a much lesser extent than diclofenac.</p><p><strong>Elimination</strong></p><p>Total systemic clearance of diclofenac from plasma is 263 &plusmn; 56 mL/min (mean value &plusmn; SD). The terminal half-life in plasma is 1-2 hours. Four of the metabolites, including the two active ones, also have short plasma half-lives of 1-3 hours. One metabolite, 3&#39;-hydroxy-4&#39;-methoxy-diclofenac, has a much longer plasma half-life. However, this metabolite is virtually inactive.</p><p>About 60% of the administered dose is excreted in the urine as the glucuronide conjugate of the intact molecule and as metabolites, most of which are also converted to glucuronide conjugates. Less than 1% is excreted as unchanged substance. The rest of the dose is eliminated as metabolites through the bile in the faeces.</p><p>Special Populations</p><p>No relevant age-dependent differences in the drug&#39;s absorption, metabolism, or excretion have been observed.</p><p>In patients suffering from renal impairment, no accumulation of the unchanged active substance can be inferred from the single-dose kinetics when applying the usual dosage schedule. At a creatinine clearance of less than &lt;10 mL/min, the calculated steady-state plasma levels of the hydroxy metabolites are about 4 times higher than in normal subjects.</p><p>However, the metabolites are ultimately cleared through the bile.</p><p>In patients with chronic hepatitis or non-decompensated cirrhosis, the kinetics and metabolism of diclofenac are the same as in patients without liver disease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical data from acute and repeated dose toxicity studies, as well as from genotoxicity, mutagenicity, and carcinogenicity studies with diclofenac revealed no specific hazard for humans at the intended therapeutic doses. In standard preclinical animal studies, there was no evidence that diclofenac had a teratogenic potential in mice, rats or rabbits.</p><p>Diclofenac had no influence on the fertility of parent animals in rats. Except for minimal fetal effects at maternally toxic doses the prenatal, perinatal, and postnatal development of the offspring was not affected.</p><p>Administration of NSAIDs (including diclofenac) inhibited ovulation in the rabbit and implantation and placentation in the rat, and led to premature closure of the ductus arteriosus in the pregnant rat. Maternally toxic doses of diclofenac were associated with dystocia, prolonged gestation, decreased fetal survival, and intrauterine growth retardation in rats.</p><p>The slight effects of diclofenac on reproduction parameters and delivery as well as constriction of the ductus arteriosus in utero are pharmacologic consequences of this class of prostaglandin synthesis inhibitors (see sections 4.3 Contraindications and 4.6 Fertility, pregnancy and lactation).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Potassium hydrogen carbonate</p><p>Mannitol</p><p>Aspartame</p><p>Saccharin sodium</p><p>Glyceryl behenate</p><p>Mint flavour</p><p>Anise flavor</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this medicinal product must not be mixed with anything other than water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg; C<br />Keep in the original container to protect from light and moisture</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Diclofenac Potassium 50mg Powder are packed in Alu/Polyethylene / Paper sachet as 900mg of powder per sachet and 12 sachets per carton</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Keep all medicine out of reach and sight of children</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Medical and Cosmetic Products Company Ltd. (Riyadh Pharma)
P.O.Box 442, Riyadh 11411
Fax: +966 11 265 0505
Email: contact@riyadhpharma.com
For any information about this medicinal product, please contact the local representative of marketing authorisation
holder:
Saudi Arabia
Marketing department
Riyadh
Tel: +966 11 265 0111
Email: marketing@riyadhpharma.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                8/2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>